| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphatidylethanolamine Binding Protein | 26 | 2022 | 37 | 6.690 |
Why?
|
| Tumor Suppressor Proteins | 15 | 2012 | 279 | 2.940 |
Why?
|
| Mitogen-Activated Protein Kinases | 14 | 2013 | 222 | 2.360 |
Why?
|
| Insulysin | 24 | 2009 | 66 | 1.990 |
Why?
|
| ErbB Receptors | 31 | 2006 | 485 | 1.920 |
Why?
|
| Signal Transduction | 36 | 2022 | 3241 | 1.890 |
Why?
|
| Neoplasm Metastasis | 15 | 2023 | 1056 | 1.870 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2019 | 137 | 1.680 |
Why?
|
| Protein Kinase C | 22 | 2022 | 270 | 1.560 |
Why?
|
| Epidermal Growth Factor | 22 | 2010 | 119 | 1.520 |
Why?
|
| Proto-Oncogene Proteins c-raf | 13 | 2014 | 47 | 1.400 |
Why?
|
| Animals | 138 | 2022 | 26582 | 1.340 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 14 | 1999 | 85 | 1.290 |
Why?
|
| Phosphorylation | 37 | 2022 | 1106 | 1.270 |
Why?
|
| Breast Neoplasms | 14 | 2023 | 2903 | 1.230 |
Why?
|
| Neurons | 21 | 2005 | 1546 | 1.220 |
Why?
|
| MAP Kinase Signaling System | 15 | 2021 | 192 | 1.210 |
Why?
|
| MicroRNAs | 6 | 2013 | 534 | 1.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2016 | 1197 | 1.140 |
Why?
|
| Rats | 56 | 2011 | 3990 | 1.140 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 4 | 2023 | 41 | 1.140 |
Why?
|
| Cell Nucleus | 9 | 2011 | 579 | 1.120 |
Why?
|
| Cell Line | 49 | 2011 | 2468 | 1.080 |
Why?
|
| Tuberous Sclerosis | 6 | 2009 | 28 | 1.080 |
Why?
|
| HMGA2 Protein | 3 | 2015 | 14 | 1.070 |
Why?
|
| Cytoplasm | 6 | 2011 | 281 | 1.030 |
Why?
|
| Protein Kinases | 9 | 2021 | 209 | 1.020 |
Why?
|
| Mice | 57 | 2022 | 11352 | 1.000 |
Why?
|
| Cell Line, Tumor | 22 | 2021 | 2426 | 0.980 |
Why?
|
| Enzyme Activation | 26 | 2013 | 692 | 0.920 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2013 | 645 | 0.900 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 6 | 2007 | 115 | 0.880 |
Why?
|
| Sirolimus | 5 | 2011 | 169 | 0.860 |
Why?
|
| Transfection | 25 | 2012 | 896 | 0.840 |
Why?
|
| TOR Serine-Threonine Kinases | 10 | 2011 | 182 | 0.830 |
Why?
|
| Insulin | 13 | 2008 | 1160 | 0.830 |
Why?
|
| Cells, Cultured | 38 | 2013 | 2818 | 0.830 |
Why?
|
| Hippocampus | 15 | 2005 | 442 | 0.820 |
Why?
|
| Chemotaxis | 2 | 2015 | 72 | 0.820 |
Why?
|
| Guanine Nucleotide Exchange Factors | 4 | 2012 | 73 | 0.810 |
Why?
|
| rap1 GTP-Binding Proteins | 2 | 2012 | 13 | 0.810 |
Why?
|
| Neovascularization, Pathologic | 5 | 2013 | 353 | 0.780 |
Why?
|
| Humans | 119 | 2023 | 86645 | 0.780 |
Why?
|
| Gene Regulatory Networks | 3 | 2014 | 296 | 0.770 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2014 | 427 | 0.730 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2022 | 107 | 0.730 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2009 | 379 | 0.710 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 8 | 2012 | 36 | 0.700 |
Why?
|
| Hemin | 1 | 2019 | 5 | 0.700 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2014 | 157 | 0.680 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 5 | 2011 | 44 | 0.670 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2013 | 138 | 0.660 |
Why?
|
| Mice, Nude | 9 | 2021 | 790 | 0.650 |
Why?
|
| Apoptosis | 13 | 2012 | 1683 | 0.640 |
Why?
|
| Cell Cycle | 9 | 2010 | 502 | 0.630 |
Why?
|
| Growth Substances | 8 | 2005 | 80 | 0.630 |
Why?
|
| Models, Biological | 9 | 2015 | 1749 | 0.610 |
Why?
|
| raf Kinases | 6 | 2010 | 12 | 0.610 |
Why?
|
| Metformin | 1 | 2019 | 128 | 0.600 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 124 | 0.600 |
Why?
|
| Macrophages | 4 | 2019 | 554 | 0.600 |
Why?
|
| Cell Proliferation | 11 | 2013 | 1578 | 0.590 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2017 | 72 | 0.590 |
Why?
|
| HeLa Cells | 12 | 2012 | 498 | 0.570 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 532 | 0.570 |
Why?
|
| Isoenzymes | 5 | 2008 | 271 | 0.570 |
Why?
|
| Adenylyl Cyclases | 2 | 2007 | 100 | 0.560 |
Why?
|
| Cyclic AMP | 3 | 2012 | 273 | 0.550 |
Why?
|
| Stromal Cells | 1 | 2016 | 143 | 0.550 |
Why?
|
| Mitosis | 3 | 2010 | 153 | 0.540 |
Why?
|
| Molecular Sequence Data | 21 | 2006 | 3030 | 0.530 |
Why?
|
| Mitochondria | 1 | 2019 | 535 | 0.520 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 8 | 2012 | 101 | 0.520 |
Why?
|
| Chemokines | 1 | 2015 | 73 | 0.520 |
Why?
|
| Androgen-Binding Protein | 2 | 2006 | 7 | 0.520 |
Why?
|
| Carcinogens | 8 | 1999 | 108 | 0.510 |
Why?
|
| DNA-Binding Proteins | 5 | 2013 | 1208 | 0.510 |
Why?
|
| Myocytes, Cardiac | 1 | 2017 | 275 | 0.500 |
Why?
|
| Amino Acid Sequence | 19 | 2009 | 2062 | 0.490 |
Why?
|
| Myocardium | 1 | 2017 | 529 | 0.490 |
Why?
|
| Syndecan-2 | 1 | 2013 | 1 | 0.480 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2013 | 4 | 0.470 |
Why?
|
| Ribosomal Protein S6 | 2 | 2010 | 4 | 0.470 |
Why?
|
| Fibroblasts | 13 | 2011 | 729 | 0.470 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2011 | 1076 | 0.470 |
Why?
|
| Phorbol 12,13-Dibutyrate | 11 | 1999 | 20 | 0.450 |
Why?
|
| Protein Binding | 13 | 2017 | 1456 | 0.440 |
Why?
|
| Fibroblast Growth Factor 2 | 5 | 2003 | 57 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 4 | 2011 | 1052 | 0.440 |
Why?
|
| Base Sequence | 16 | 2010 | 2330 | 0.430 |
Why?
|
| Gene Expression Regulation | 9 | 2011 | 1920 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2001 | 302 | 0.420 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 418 | 0.420 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2008 | 557 | 0.410 |
Why?
|
| Repressor Proteins | 5 | 2004 | 403 | 0.410 |
Why?
|
| Proteins | 7 | 2010 | 777 | 0.410 |
Why?
|
| MAP Kinase Kinase 5 | 2 | 2009 | 11 | 0.410 |
Why?
|
| Fibroblast Growth Factors | 5 | 1999 | 80 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2009 | 21 | 0.410 |
Why?
|
| Transcription, Genetic | 13 | 2014 | 1135 | 0.410 |
Why?
|
| Carrier Proteins | 5 | 2009 | 673 | 0.400 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 536 | 0.400 |
Why?
|
| RNA, Messenger | 16 | 2022 | 1981 | 0.390 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2009 | 43 | 0.390 |
Why?
|
| Neoplasms | 8 | 2021 | 2898 | 0.390 |
Why?
|
| Oncogene Protein v-akt | 3 | 2006 | 21 | 0.370 |
Why?
|
| Transcriptome | 2 | 2013 | 580 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2010 | 322 | 0.360 |
Why?
|
| Prognosis | 6 | 2016 | 3680 | 0.360 |
Why?
|
| Thrombospondins | 1 | 2009 | 14 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 4 | 2009 | 503 | 0.360 |
Why?
|
| Drosophila melanogaster | 7 | 2001 | 599 | 0.350 |
Why?
|
| Oxazolidinones | 1 | 2009 | 11 | 0.350 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 316 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 8 | 2013 | 74 | 0.350 |
Why?
|
| Blotting, Western | 8 | 2012 | 782 | 0.350 |
Why?
|
| Acrylamides | 4 | 1989 | 30 | 0.340 |
Why?
|
| Cnidarian Venoms | 4 | 1989 | 19 | 0.340 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 27 | 0.340 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 696 | 0.340 |
Why?
|
| Allosteric Regulation | 1 | 2008 | 68 | 0.330 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2021 | 589 | 0.330 |
Why?
|
| Cloning, Molecular | 7 | 2002 | 646 | 0.330 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2001 | 279 | 0.330 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 179 | 0.330 |
Why?
|
| Substrate Specificity | 12 | 2012 | 347 | 0.320 |
Why?
|
| Promoter Regions, Genetic | 8 | 2014 | 937 | 0.320 |
Why?
|
| Transcription Factors | 8 | 2022 | 1565 | 0.320 |
Why?
|
| Kinetics | 17 | 1998 | 1513 | 0.310 |
Why?
|
| Endothelial Cells | 2 | 2009 | 428 | 0.310 |
Why?
|
| Carcinoma | 1 | 2011 | 436 | 0.310 |
Why?
|
| Cell Division | 10 | 2008 | 696 | 0.310 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 2 | 1997 | 12 | 0.310 |
Why?
|
| Trachea | 6 | 2002 | 293 | 0.310 |
Why?
|
| Telomere-Binding Proteins | 1 | 2007 | 14 | 0.300 |
Why?
|
| Muscle, Smooth | 6 | 2002 | 354 | 0.300 |
Why?
|
| Conserved Sequence | 4 | 2017 | 210 | 0.300 |
Why?
|
| Heterografts | 2 | 2019 | 98 | 0.300 |
Why?
|
| RNA Interference | 3 | 2013 | 369 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 3092 | 0.290 |
Why?
|
| Thapsigargin | 6 | 1997 | 55 | 0.290 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 246 | 0.290 |
Why?
|
| Down-Regulation | 9 | 2013 | 504 | 0.290 |
Why?
|
| bcl-Associated Death Protein | 1 | 2006 | 16 | 0.280 |
Why?
|
| Retina | 3 | 1993 | 213 | 0.280 |
Why?
|
| Gene Expression Profiling | 5 | 2015 | 1384 | 0.280 |
Why?
|
| Female | 24 | 2023 | 44534 | 0.280 |
Why?
|
| Spindle Apparatus | 1 | 2006 | 65 | 0.280 |
Why?
|
| RNA, Neoplasm | 2 | 2016 | 87 | 0.280 |
Why?
|
| Serine | 4 | 2017 | 99 | 0.280 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 87 | 0.270 |
Why?
|
| Enzyme Inhibitors | 8 | 2003 | 639 | 0.270 |
Why?
|
| Cyclin D1 | 7 | 2011 | 83 | 0.270 |
Why?
|
| Rett Syndrome | 1 | 2005 | 19 | 0.270 |
Why?
|
| Cell Fusion | 1 | 2005 | 39 | 0.270 |
Why?
|
| 14-3-3 Proteins | 1 | 2005 | 10 | 0.270 |
Why?
|
| Spasms, Infantile | 1 | 2005 | 30 | 0.270 |
Why?
|
| Cell Differentiation | 12 | 2005 | 1458 | 0.270 |
Why?
|
| Mutation | 14 | 2016 | 3968 | 0.270 |
Why?
|
| Structure-Activity Relationship | 5 | 2014 | 408 | 0.270 |
Why?
|
| Cell Survival | 9 | 2011 | 969 | 0.270 |
Why?
|
| DNA | 10 | 2005 | 1294 | 0.260 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 1721 | 0.260 |
Why?
|
| Transplantation, Heterologous | 3 | 2016 | 363 | 0.260 |
Why?
|
| Cattle | 10 | 2005 | 376 | 0.260 |
Why?
|
| Cell Cycle Proteins | 4 | 2012 | 388 | 0.260 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2002 | 416 | 0.250 |
Why?
|
| Biological Evolution | 5 | 2015 | 919 | 0.250 |
Why?
|
| Gene Expression | 8 | 2013 | 1284 | 0.250 |
Why?
|
| Peptide Hydrolases | 3 | 1989 | 100 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 2 | 2016 | 217 | 0.250 |
Why?
|
| Immunohistochemistry | 9 | 2012 | 1753 | 0.250 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 2 | 2014 | 8 | 0.240 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 64 | 0.240 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 977 | 0.240 |
Why?
|
| Cell Line, Transformed | 7 | 2003 | 154 | 0.240 |
Why?
|
| NF-kappa B | 5 | 2009 | 444 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 689 | 0.230 |
Why?
|
| Zinc | 2 | 1994 | 91 | 0.230 |
Why?
|
| Immunity, Innate | 2 | 2022 | 409 | 0.230 |
Why?
|
| Ubiquitin | 1 | 2004 | 93 | 0.230 |
Why?
|
| Transforming Growth Factor alpha | 3 | 1997 | 50 | 0.230 |
Why?
|
| RNA, Small Interfering | 6 | 2013 | 547 | 0.230 |
Why?
|
| RNA, Transfer | 3 | 2016 | 151 | 0.230 |
Why?
|
| Threonine | 3 | 1993 | 33 | 0.230 |
Why?
|
| Phenotype | 5 | 2019 | 2378 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2010 | 1961 | 0.220 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 9 | 0.220 |
Why?
|
| COS Cells | 5 | 2002 | 166 | 0.220 |
Why?
|
| DNA, Neoplasm | 4 | 2009 | 265 | 0.220 |
Why?
|
| Tissue Distribution | 4 | 2011 | 290 | 0.220 |
Why?
|
| Protein Biosynthesis | 5 | 2013 | 378 | 0.220 |
Why?
|
| Methylprednisolone | 2 | 1992 | 66 | 0.220 |
Why?
|
| Protein Isoforms | 3 | 2011 | 270 | 0.220 |
Why?
|
| ras Proteins | 2 | 2007 | 128 | 0.210 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 53 | 0.210 |
Why?
|
| Radiation Injuries, Experimental | 2 | 1992 | 41 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Butadienes | 4 | 2016 | 33 | 0.210 |
Why?
|
| Genes, Immediate-Early | 2 | 1999 | 17 | 0.210 |
Why?
|
| MAP Kinase Kinase 2 | 3 | 2016 | 14 | 0.200 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 1204 | 0.200 |
Why?
|
| Clone Cells | 4 | 2015 | 213 | 0.200 |
Why?
|
| Nitriles | 4 | 2016 | 149 | 0.200 |
Why?
|
| Cricetinae | 8 | 2009 | 560 | 0.200 |
Why?
|
| Imatinib Mesylate | 1 | 2021 | 126 | 0.200 |
Why?
|
| Light | 2 | 1992 | 289 | 0.200 |
Why?
|
| Immunoblotting | 2 | 2013 | 268 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 6 | 2006 | 736 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 552 | 0.200 |
Why?
|
| Protein Conformation | 4 | 2014 | 881 | 0.200 |
Why?
|
| Amniotic Fluid | 2 | 2011 | 30 | 0.190 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 864 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 592 | 0.190 |
Why?
|
| Calcium | 4 | 1994 | 1156 | 0.190 |
Why?
|
| Receptors, Cell Surface | 4 | 1989 | 286 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 879 | 0.190 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 79 | 0.190 |
Why?
|
| Cyclins | 2 | 1997 | 82 | 0.190 |
Why?
|
| Cyclin E | 2 | 2012 | 27 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 9 | 2011 | 1041 | 0.190 |
Why?
|
| Microbodies | 2 | 1997 | 7 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2013 | 68 | 0.190 |
Why?
|
| Blotting, Northern | 5 | 2002 | 256 | 0.190 |
Why?
|
| Leucine | 2 | 1997 | 67 | 0.190 |
Why?
|
| DNA Primers | 4 | 2010 | 543 | 0.180 |
Why?
|
| Terpenes | 3 | 1996 | 17 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 231 | 0.180 |
Why?
|
| Transforming Growth Factors | 2 | 1989 | 12 | 0.180 |
Why?
|
| Protein Kinase C-delta | 4 | 2006 | 26 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2005 | 214 | 0.170 |
Why?
|
| Proline | 1 | 1999 | 57 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2013 | 1924 | 0.170 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 21 | 0.170 |
Why?
|
| Tyrosine | 6 | 2005 | 133 | 0.170 |
Why?
|
| Electron Transport | 1 | 2019 | 71 | 0.170 |
Why?
|
| Alkaloids | 3 | 2006 | 45 | 0.170 |
Why?
|
| Glutamine | 1 | 1999 | 76 | 0.170 |
Why?
|
| Binding Sites | 5 | 2010 | 1098 | 0.170 |
Why?
|
| Indoles | 2 | 2011 | 318 | 0.170 |
Why?
|
| Escherichia coli | 2 | 2000 | 597 | 0.170 |
Why?
|
| Chloride Channels | 1 | 1999 | 42 | 0.170 |
Why?
|
| Receptor, Insulin | 3 | 1990 | 54 | 0.170 |
Why?
|
| NIH 3T3 Cells | 3 | 2010 | 105 | 0.170 |
Why?
|
| Proteolysis | 1 | 2019 | 100 | 0.160 |
Why?
|
| Aging | 2 | 1993 | 691 | 0.160 |
Why?
|
| PC12 Cells | 5 | 2002 | 115 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 276 | 0.160 |
Why?
|
| Stem Cells | 2 | 2011 | 351 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2007 | 114 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2007 | 262 | 0.160 |
Why?
|
| Molecular Weight | 8 | 1996 | 332 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2006 | 189 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2022 | 510 | 0.160 |
Why?
|
| Recombinant Proteins | 5 | 2001 | 1014 | 0.160 |
Why?
|
| Sodium | 2 | 1989 | 341 | 0.160 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 83 | 0.160 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 48 | 0.150 |
Why?
|
| Obesity | 2 | 2019 | 963 | 0.150 |
Why?
|
| Retroviridae Proteins, Oncogenic | 2 | 1998 | 9 | 0.150 |
Why?
|
| Mouth Mucosa | 2 | 2009 | 67 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 458 | 0.150 |
Why?
|
| Drosophila Proteins | 3 | 2001 | 488 | 0.150 |
Why?
|
| Protein Transport | 3 | 2010 | 411 | 0.150 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1998 | 153 | 0.150 |
Why?
|
| Cytoskeleton | 2 | 2009 | 193 | 0.150 |
Why?
|
| Epithelial Cells | 3 | 2022 | 669 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2019 | 240 | 0.150 |
Why?
|
| Plant Extracts | 2 | 1989 | 244 | 0.140 |
Why?
|
| DNA, Complementary | 4 | 2002 | 393 | 0.140 |
Why?
|
| Metalloendopeptidases | 3 | 1991 | 45 | 0.140 |
Why?
|
| Biomarkers, Tumor | 3 | 2014 | 1464 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 1996 | 10 | 0.140 |
Why?
|
| Oxidative Stress | 3 | 2014 | 447 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2007 | 41 | 0.140 |
Why?
|
| Amyloid beta-Peptides | 4 | 2006 | 203 | 0.140 |
Why?
|
| Cadherins | 1 | 2016 | 151 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 1047 | 0.140 |
Why?
|
| Glucose | 1 | 2019 | 638 | 0.140 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2010 | 29 | 0.140 |
Why?
|
| Plasmids | 4 | 2012 | 287 | 0.140 |
Why?
|
| Antigens, Bacterial | 2 | 2007 | 134 | 0.140 |
Why?
|
| Cyclohexanes | 1 | 2015 | 9 | 0.140 |
Why?
|
| Bacterial Toxins | 2 | 2007 | 111 | 0.140 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 17 | 0.140 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 16 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 1219 | 0.130 |
Why?
|
| Histamine | 1 | 1995 | 126 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 371 | 0.130 |
Why?
|
| Mitogens | 2 | 2002 | 64 | 0.130 |
Why?
|
| Stochastic Processes | 1 | 2015 | 74 | 0.130 |
Why?
|
| Multiprotein Complexes | 3 | 2010 | 95 | 0.130 |
Why?
|
| Male | 13 | 2022 | 40967 | 0.130 |
Why?
|
| Precipitin Tests | 3 | 2002 | 108 | 0.130 |
Why?
|
| Triazoles | 1 | 2015 | 96 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 236 | 0.130 |
Why?
|
| Dacryocystorhinostomy | 1 | 1994 | 4 | 0.120 |
Why?
|
| Genes, Regulator | 1 | 1994 | 65 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2007 | 199 | 0.120 |
Why?
|
| Conjunctiva | 1 | 1994 | 19 | 0.120 |
Why?
|
| Glioma | 2 | 2012 | 285 | 0.120 |
Why?
|
| Pyramidal Cells | 1 | 1994 | 80 | 0.120 |
Why?
|
| Neurites | 3 | 1999 | 35 | 0.120 |
Why?
|
| Heart | 1 | 2017 | 539 | 0.120 |
Why?
|
| CHO Cells | 4 | 2009 | 187 | 0.120 |
Why?
|
| Chromatography, Affinity | 3 | 2001 | 81 | 0.120 |
Why?
|
| Amino Acid Motifs | 3 | 2014 | 116 | 0.120 |
Why?
|
| Phorbol Esters | 4 | 1987 | 22 | 0.120 |
Why?
|
| Endopeptidases | 2 | 1991 | 116 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2008 | 258 | 0.120 |
Why?
|
| Wnt1 Protein | 1 | 2013 | 24 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 121 | 0.120 |
Why?
|
| Phospholipids | 1 | 2014 | 111 | 0.120 |
Why?
|
| Staining and Labeling | 2 | 2010 | 165 | 0.120 |
Why?
|
| Chromatin | 2 | 2006 | 380 | 0.120 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 2360 | 0.120 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 2002 | 67 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2014 | 1286 | 0.110 |
Why?
|
| Animals, Newborn | 2 | 1995 | 510 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1993 | 46 | 0.110 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2013 | 18 | 0.110 |
Why?
|
| RNA, Transfer, Amino Acyl | 1 | 2013 | 11 | 0.110 |
Why?
|
| Mixed Function Oxygenases | 1 | 2013 | 68 | 0.110 |
Why?
|
| RNA, Transfer, Ser | 1 | 2012 | 2 | 0.110 |
Why?
|
| Electrodes | 1 | 1993 | 78 | 0.110 |
Why?
|
| Ethers, Cyclic | 1 | 1992 | 7 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1540 | 0.110 |
Why?
|
| Electroretinography | 1 | 1993 | 76 | 0.110 |
Why?
|
| Embryo, Mammalian | 3 | 2006 | 207 | 0.110 |
Why?
|
| Survival Rate | 1 | 2016 | 1863 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1992 | 57 | 0.110 |
Why?
|
| Rabbits | 3 | 2000 | 636 | 0.110 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 2001 | 36 | 0.110 |
Why?
|
| Methionine | 2 | 2009 | 66 | 0.110 |
Why?
|
| Thymidine | 3 | 2010 | 59 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 301 | 0.110 |
Why?
|
| Disease Progression | 4 | 2014 | 1531 | 0.110 |
Why?
|
| Testis | 2 | 2005 | 152 | 0.110 |
Why?
|
| Methylmercury Compounds | 1 | 2011 | 3 | 0.110 |
Why?
|
| Cell Movement | 2 | 2021 | 758 | 0.110 |
Why?
|
| Drosophila | 4 | 1994 | 498 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2022 | 83 | 0.100 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 391 | 0.100 |
Why?
|
| Interferons | 2 | 2022 | 133 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 376 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 273 | 0.100 |
Why?
|
| Chromatography, Gel | 6 | 2000 | 103 | 0.100 |
Why?
|
| Endoribonucleases | 2 | 2022 | 92 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2011 | 96 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2011 | 89 | 0.100 |
Why?
|
| G1 Phase | 1 | 2011 | 63 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 318 | 0.100 |
Why?
|
| Toxins, Biological | 1 | 1990 | 7 | 0.100 |
Why?
|
| Time Factors | 8 | 2015 | 5210 | 0.100 |
Why?
|
| Proto-Oncogenes | 2 | 1989 | 61 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2004 | 351 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 132 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 860 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 1994 | 455 | 0.100 |
Why?
|
| Models, Theoretical | 2 | 2014 | 482 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 407 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2002 | 348 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 645 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 912 | 0.090 |
Why?
|
| fas Receptor | 2 | 2001 | 75 | 0.090 |
Why?
|
| Sarcoma Virus, Woolly Monkey | 1 | 1989 | 1 | 0.090 |
Why?
|
| Retroviruses, Simian | 1 | 1989 | 1 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 275 | 0.090 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2009 | 18 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2000 | 69 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 409 | 0.090 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2009 | 8 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 827 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2010 | 61 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 623 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2013 | 1538 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2009 | 35 | 0.090 |
Why?
|
| Vimentin | 1 | 2009 | 44 | 0.090 |
Why?
|
| Liver | 3 | 1993 | 1230 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2007 | 75 | 0.090 |
Why?
|
| Glycoproteins | 4 | 1986 | 234 | 0.090 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2009 | 22 | 0.080 |
Why?
|
| RNA | 3 | 2005 | 560 | 0.080 |
Why?
|
| Diglycerides | 2 | 1987 | 22 | 0.080 |
Why?
|
| Breast | 2 | 2009 | 288 | 0.080 |
Why?
|
| Viral Proteins | 4 | 1986 | 300 | 0.080 |
Why?
|
| Muscles | 1 | 1989 | 194 | 0.080 |
Why?
|
| Rats, Inbred Lew | 3 | 1993 | 186 | 0.080 |
Why?
|
| Receptors, Estrogen | 3 | 2007 | 384 | 0.080 |
Why?
|
| Tretinoin | 1 | 1989 | 126 | 0.080 |
Why?
|
| Feedback, Physiological | 2 | 2022 | 62 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 683 | 0.080 |
Why?
|
| Fibronectins | 1 | 1988 | 93 | 0.080 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2008 | 23 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2006 | 113 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2008 | 79 | 0.080 |
Why?
|
| 3T3 Cells | 4 | 1996 | 94 | 0.080 |
Why?
|
| Protease Inhibitors | 3 | 1996 | 72 | 0.080 |
Why?
|
| Tubulin | 1 | 2008 | 58 | 0.080 |
Why?
|
| Genes | 1 | 1988 | 305 | 0.080 |
Why?
|
| Gene Library | 2 | 2002 | 130 | 0.080 |
Why?
|
| Kidney | 5 | 1999 | 1241 | 0.080 |
Why?
|
| Simian virus 40 | 3 | 2003 | 35 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 115 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 927 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1993 | 173 | 0.080 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2007 | 8 | 0.080 |
Why?
|
| Catalysis | 2 | 2001 | 203 | 0.080 |
Why?
|
| Receptors, Peptide | 1 | 2007 | 16 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1313 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2705 | 0.070 |
Why?
|
| DNA, Recombinant | 1 | 1986 | 67 | 0.070 |
Why?
|
| Temperature | 4 | 2003 | 396 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2013 | 2767 | 0.070 |
Why?
|
| Alanine | 2 | 1997 | 85 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2013 | 7993 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 1996 | 47 | 0.070 |
Why?
|
| Secretoglobins | 1 | 2006 | 1 | 0.070 |
Why?
|
| Prostatein | 1 | 2006 | 1 | 0.070 |
Why?
|
| Uteroglobin | 1 | 2006 | 4 | 0.070 |
Why?
|
| Estradiol | 2 | 1999 | 252 | 0.070 |
Why?
|
| Nocodazole | 1 | 2006 | 18 | 0.070 |
Why?
|
| Kinetochores | 1 | 2006 | 7 | 0.070 |
Why?
|
| Aurora Kinases | 1 | 2006 | 17 | 0.070 |
Why?
|
| Metaphase | 1 | 2006 | 25 | 0.070 |
Why?
|
| Aurora Kinase B | 1 | 2006 | 14 | 0.070 |
Why?
|
| Centrosome | 1 | 2006 | 22 | 0.070 |
Why?
|
| Moloney murine leukemia virus | 1 | 1986 | 5 | 0.070 |
Why?
|
| BRCA2 Protein | 1 | 2007 | 158 | 0.070 |
Why?
|
| Benzophenanthridines | 1 | 2006 | 23 | 0.070 |
Why?
|
| Phenanthridines | 1 | 2006 | 24 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2006 | 65 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 63 | 0.070 |
Why?
|
| Ligands | 3 | 2010 | 433 | 0.070 |
Why?
|
| Receptors, Virus | 1 | 1986 | 74 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 1987 | 176 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 200 | 0.070 |
Why?
|
| Binding, Competitive | 3 | 1993 | 145 | 0.070 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2005 | 16 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1991 | 245 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 763 | 0.070 |
Why?
|
| Electrophysiology | 2 | 1999 | 401 | 0.070 |
Why?
|
| Fas Ligand Protein | 2 | 2006 | 49 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 143 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2011 | 121 | 0.070 |
Why?
|
| Brain | 4 | 2005 | 2216 | 0.070 |
Why?
|
| Asparagine | 2 | 1983 | 29 | 0.070 |
Why?
|
| Cross Reactions | 2 | 2001 | 106 | 0.070 |
Why?
|
| Cell Shape | 1 | 2005 | 51 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2006 | 143 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2006 | 485 | 0.070 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2007 | 44 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2000 | 176 | 0.070 |
Why?
|
| Aspartic Acid | 1 | 2005 | 64 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2005 | 156 | 0.070 |
Why?
|
| Transcriptional Activation | 2 | 1998 | 280 | 0.070 |
Why?
|
| DNA Replication | 4 | 1995 | 164 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 134 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 712 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 2001 | 1074 | 0.060 |
Why?
|
| Glycerides | 1 | 1984 | 17 | 0.060 |
Why?
|
| Phorbols | 1 | 1984 | 9 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2006 | 460 | 0.060 |
Why?
|
| Cysteine | 2 | 1996 | 135 | 0.060 |
Why?
|
| Mouth Neoplasms | 1 | 2006 | 194 | 0.060 |
Why?
|
| Serotonin | 2 | 1995 | 218 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 100 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2009 | 302 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 503 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 268 | 0.060 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2003 | 5 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 428 | 0.060 |
Why?
|
| Hydrolysis | 3 | 2006 | 141 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 132 | 0.060 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2022 | 17 | 0.060 |
Why?
|
| Inositol | 1 | 2022 | 15 | 0.060 |
Why?
|
| Iodine Radioisotopes | 2 | 1997 | 134 | 0.060 |
Why?
|
| Bronchi | 1 | 2003 | 229 | 0.050 |
Why?
|
| Cystatin M | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cystatins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2000 | 36 | 0.050 |
Why?
|
| Cathepsins | 1 | 2002 | 21 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
| Polyisoprenyl Phosphate Oligosaccharides | 1 | 1982 | 1 | 0.050 |
Why?
|
| Polyisoprenyl Phosphate Sugars | 1 | 1982 | 1 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 100 | 0.050 |
Why?
|
| Glycosylation | 1 | 2002 | 129 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2002 | 74 | 0.050 |
Why?
|
| Androstadienes | 2 | 1999 | 72 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 666 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2003 | 15 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 111 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 85 | 0.050 |
Why?
|
| Cell Compartmentation | 2 | 2001 | 69 | 0.050 |
Why?
|
| Tissue Extracts | 2 | 2008 | 24 | 0.050 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2001 | 13 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 20 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2001 | 33 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2022 | 90 | 0.050 |
Why?
|
| Egtazic Acid | 2 | 1992 | 34 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 43 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 1989 | 460 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 88 | 0.050 |
Why?
|
| Nerve Growth Factors | 2 | 1999 | 63 | 0.050 |
Why?
|
| Caspases | 1 | 2001 | 155 | 0.050 |
Why?
|
| Rauscher Virus | 1 | 1980 | 8 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 289 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2001 | 129 | 0.050 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2000 | 5 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2001 | 199 | 0.050 |
Why?
|
| Protein Kinase C-theta | 1 | 2000 | 16 | 0.050 |
Why?
|
| Amino Acids | 3 | 1988 | 252 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2021 | 224 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2001 | 132 | 0.050 |
Why?
|
| X Chromosome | 1 | 2001 | 152 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 2 | 1998 | 20 | 0.050 |
Why?
|
| Virus Replication | 1 | 2022 | 319 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 1980 | 143 | 0.050 |
Why?
|
| Nucleotides | 2 | 2011 | 95 | 0.050 |
Why?
|
| Histidine | 1 | 2000 | 55 | 0.050 |
Why?
|
| Amino Acid Substitution | 2 | 2017 | 339 | 0.050 |
Why?
|
| Exons | 1 | 2002 | 450 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 49 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1989 | 315 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 314 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 208 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2001 | 276 | 0.040 |
Why?
|
| Septal Nuclei | 1 | 1999 | 9 | 0.040 |
Why?
|
| Calcimycin | 2 | 1990 | 33 | 0.040 |
Why?
|
| Codon, Initiator | 1 | 1999 | 21 | 0.040 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2019 | 6 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2001 | 458 | 0.040 |
Why?
|
| Benzopyrans | 1 | 1999 | 20 | 0.040 |
Why?
|
| Acetophenones | 1 | 1999 | 27 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 22 | 0.040 |
Why?
|
| Oligosaccharides | 4 | 1983 | 24 | 0.040 |
Why?
|
| Infant | 1 | 2005 | 3047 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1999 | 56 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 93 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 146 | 0.040 |
Why?
|
| Cell Transformation, Viral | 2 | 2003 | 40 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 78 | 0.040 |
Why?
|
| Chick Embryo | 3 | 2012 | 229 | 0.040 |
Why?
|
| Bombesin | 2 | 1989 | 6 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2010 | 493 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2000 | 439 | 0.040 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1998 | 8 | 0.040 |
Why?
|
| Troponin C | 1 | 2017 | 2 | 0.040 |
Why?
|
| Serum Response Factor | 1 | 1998 | 44 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1997 | 9 | 0.040 |
Why?
|
| Dactinomycin | 2 | 2006 | 36 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 47 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1997 | 28 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 256 | 0.040 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1997 | 3 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1997 | 26 | 0.040 |
Why?
|
| Microinjections | 1 | 1997 | 70 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2017 | 63 | 0.040 |
Why?
|
| Cell Size | 2 | 2011 | 65 | 0.040 |
Why?
|
| Affinity Labels | 2 | 1988 | 10 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1998 | 205 | 0.040 |
Why?
|
| Weight Loss | 1 | 2019 | 229 | 0.040 |
Why?
|
| Valine | 1 | 1997 | 69 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 148 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 195 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1996 | 381 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 59 | 0.040 |
Why?
|
| Flavonoids | 1 | 1997 | 85 | 0.040 |
Why?
|
| Membrane Proteins | 4 | 2000 | 1196 | 0.040 |
Why?
|
| Caspase 1 | 1 | 1996 | 18 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1996 | 25 | 0.040 |
Why?
|
| Lysine | 1 | 2017 | 147 | 0.040 |
Why?
|
| Blotting, Southern | 3 | 1997 | 129 | 0.040 |
Why?
|
| Phylogeny | 1 | 2002 | 1137 | 0.040 |
Why?
|
| Oncogene Proteins v-raf | 1 | 1996 | 2 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 1170 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1993 | 312 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1997 | 329 | 0.030 |
Why?
|
| Genes, Wilms Tumor | 1 | 1995 | 6 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 853 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1988 | 989 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 443 | 0.030 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1995 | 12 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 34 | 0.030 |
Why?
|
| Adult | 6 | 2013 | 25648 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2015 | 37 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 1992 | 2232 | 0.030 |
Why?
|
| Genetic Fitness | 1 | 2015 | 37 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 73 | 0.030 |
Why?
|
| NADPH Oxidases | 2 | 2009 | 81 | 0.030 |
Why?
|
| Cytosol | 2 | 2000 | 189 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1994 | 71 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1994 | 58 | 0.030 |
Why?
|
| Nasolacrimal Duct | 1 | 1994 | 2 | 0.030 |
Why?
|
| Aged | 4 | 2013 | 18415 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2010 | 88 | 0.030 |
Why?
|
| Glass | 1 | 1994 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1994 | 68 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1995 | 164 | 0.030 |
Why?
|
| Staurosporine | 2 | 1993 | 33 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 615 | 0.030 |
Why?
|
| Adenovirus E3 Proteins | 1 | 1993 | 2 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1994 | 158 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1993 | 41 | 0.030 |
Why?
|
| Point Mutation | 1 | 1994 | 246 | 0.030 |
Why?
|
| Haplorhini | 1 | 1993 | 81 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 106 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2014 | 178 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 133 | 0.030 |
Why?
|
| Glucagon | 2 | 2006 | 111 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1990 | 13 | 0.030 |
Why?
|
| Glutamates | 1 | 1993 | 89 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1993 | 63 | 0.030 |
Why?
|
| Sindbis Virus | 2 | 1983 | 4 | 0.030 |
Why?
|
| Contact Lenses | 1 | 1993 | 7 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 1993 | 152 | 0.030 |
Why?
|
| Needles | 1 | 1993 | 35 | 0.030 |
Why?
|
| Ionomycin | 1 | 1992 | 21 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 318 | 0.030 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1992 | 13 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1992 | 9 | 0.030 |
Why?
|
| Middle Aged | 4 | 2013 | 25028 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 1992 | 15 | 0.030 |
Why?
|
| Cornea | 1 | 1993 | 69 | 0.030 |
Why?
|
| Rhodopsin | 1 | 1992 | 19 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 1992 | 34 | 0.030 |
Why?
|
| Retroviridae | 1 | 1992 | 79 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 1992 | 102 | 0.030 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2012 | 4 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 2012 | 19 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 330 | 0.030 |
Why?
|
| Interphase | 1 | 2012 | 34 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2012 | 8 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 28 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 752 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2012 | 25 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 434 | 0.030 |
Why?
|
| Cyclin A | 1 | 2011 | 28 | 0.030 |
Why?
|
| Nobel Prize | 1 | 2011 | 10 | 0.030 |
Why?
|
| Cell Count | 1 | 1992 | 195 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2011 | 15 | 0.030 |
Why?
|
| Ammonium Chloride | 1 | 1991 | 22 | 0.030 |
Why?
|
| Chloroquine | 1 | 1991 | 12 | 0.030 |
Why?
|
| Antibodies | 2 | 2008 | 350 | 0.030 |
Why?
|
| Neuroglia | 1 | 1992 | 104 | 0.030 |
Why?
|
| Food Contamination | 1 | 2011 | 31 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 74 | 0.030 |
Why?
|
| Child | 2 | 2012 | 6928 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 813 | 0.030 |
Why?
|
| Cricetulus | 2 | 2009 | 126 | 0.030 |
Why?
|
| India | 1 | 2011 | 120 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 72 | 0.020 |
Why?
|
| Bacitracin | 1 | 1991 | 3 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 34 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 204 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 92 | 0.020 |
Why?
|
| Trypsin | 2 | 1989 | 95 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2011 | 51 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 133 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2015 | 502 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1991 | 47 | 0.020 |
Why?
|
| Lysosomes | 1 | 1991 | 104 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2012 | 165 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 916 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1993 | 372 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2011 | 114 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 303 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2011 | 312 | 0.020 |
Why?
|
| Imidazoles | 1 | 2011 | 162 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2002 | 268 | 0.020 |
Why?
|
| Leukemia | 1 | 1992 | 320 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 8982 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1990 | 32 | 0.020 |
Why?
|
| Biomarkers | 1 | 1996 | 1718 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 78 | 0.020 |
Why?
|
| RNA, Transfer, Met | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2009 | 39 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1989 | 19 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 728 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1989 | 26 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1989 | 31 | 0.020 |
Why?
|
| Genetic Code | 1 | 2009 | 25 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 37 | 0.020 |
Why?
|
| Genes, Dominant | 2 | 2001 | 117 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 37 | 0.020 |
Why?
|
| Monensin | 1 | 1989 | 16 | 0.020 |
Why?
|
| Culture Media | 1 | 1989 | 147 | 0.020 |
Why?
|
| Nestin | 1 | 2009 | 18 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2009 | 16 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1989 | 41 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 272 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 124 | 0.020 |
Why?
|
| Prostate | 1 | 1993 | 378 | 0.020 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2009 | 1 | 0.020 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2009 | 11 | 0.020 |
Why?
|
| Cesium | 1 | 1989 | 25 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 1988 | 3 | 0.020 |
Why?
|
| DNA Probes | 1 | 1989 | 77 | 0.020 |
Why?
|
| Half-Life | 1 | 1989 | 96 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 92 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 1989 | 18 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2002 | 137 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 1989 | 83 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1989 | 129 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2008 | 78 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 1988 | 42 | 0.020 |
Why?
|
| Endocytosis | 1 | 1989 | 177 | 0.020 |
Why?
|
| Ecdysone | 1 | 1988 | 2 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2009 | 345 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1989 | 435 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 255 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 447 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 2007 | 60 | 0.020 |
Why?
|
| Hormones | 1 | 1988 | 141 | 0.020 |
Why?
|
| Mice, Obese | 1 | 1987 | 44 | 0.020 |
Why?
|
| Oncogenes | 2 | 2003 | 88 | 0.020 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1987 | 16 | 0.020 |
Why?
|
| Electrolytes | 1 | 1987 | 52 | 0.020 |
Why?
|
| Species Specificity | 1 | 1989 | 678 | 0.020 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1987 | 20 | 0.020 |
Why?
|
| Potassium | 1 | 1989 | 281 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 1989 | 247 | 0.020 |
Why?
|
| Cell Extracts | 1 | 1987 | 15 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 1987 | 21 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1989 | 142 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1987 | 38 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 480 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 1351 | 0.020 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2006 | 25 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1991 | 384 | 0.020 |
Why?
|
| Menopause | 1 | 2007 | 71 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 1195 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1987 | 149 | 0.020 |
Why?
|
| Amyloid | 1 | 2006 | 85 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2006 | 14 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1992 | 1204 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 2006 | 15 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 49 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 1989 | 336 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1985 | 27 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 143 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 167 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 60 | 0.020 |
Why?
|
| Solubility | 1 | 1986 | 177 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 674 | 0.020 |
Why?
|
| Alzheimer Disease | 2 | 2000 | 470 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1989 | 394 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2006 | 193 | 0.020 |
Why?
|
| Phosphopeptides | 1 | 1984 | 11 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 3613 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1991 | 736 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2009 | 926 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2003 | 62 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1994 | 2207 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 6509 | 0.010 |
Why?
|
| Glucose Oxidase | 1 | 2003 | 7 | 0.010 |
Why?
|
| Hexosaminidases | 1 | 1983 | 7 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1983 | 5 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 66 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2002 | 41 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 188 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 53 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 71 | 0.010 |
Why?
|
| Bryostatins | 1 | 2002 | 15 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 86 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2002 | 71 | 0.010 |
Why?
|
| Lactones | 1 | 2002 | 28 | 0.010 |
Why?
|
| Macrolides | 1 | 2002 | 31 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2002 | 25 | 0.010 |
Why?
|
| Microsomes | 1 | 1982 | 35 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1982 | 51 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 744 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2001 | 23 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 79 | 0.010 |
Why?
|
| Hamartoma | 1 | 2001 | 31 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2001 | 85 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2001 | 86 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 177 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2001 | 88 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1980 | 101 | 0.010 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2000 | 6 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1980 | 143 | 0.010 |
Why?
|
| Biotin | 1 | 2000 | 44 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2000 | 55 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5976 | 0.010 |
Why?
|
| Onium Compounds | 1 | 1999 | 4 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2000 | 90 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1999 | 25 | 0.010 |
Why?
|
| Luciferases | 1 | 1999 | 118 | 0.010 |
Why?
|
| United States | 1 | 2011 | 6674 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 71 | 0.010 |
Why?
|
| Carmustine | 1 | 1999 | 70 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2271 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2000 | 254 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 104 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1998 | 52 | 0.010 |
Why?
|
| Microglia | 1 | 1998 | 102 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1999 | 138 | 0.010 |
Why?
|
| Cell Death | 1 | 1999 | 256 | 0.010 |
Why?
|
| S Phase | 1 | 1997 | 62 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 155 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2000 | 378 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 426 | 0.010 |
Why?
|
| DNA Repair | 1 | 1999 | 356 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 894 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 1995 | 19 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 584 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1995 | 54 | 0.010 |
Why?
|
| Asthma | 1 | 2003 | 955 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 621 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 29 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1995 | 158 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1995 | 201 | 0.010 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1992 | 14 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1993 | 135 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1994 | 326 | 0.010 |
Why?
|
| Virus Activation | 1 | 1992 | 41 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 1992 | 27 | 0.010 |
Why?
|
| Mammals | 1 | 1994 | 227 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1991 | 72 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1991 | 74 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1993 | 272 | 0.010 |
Why?
|
| Apgar Score | 1 | 1989 | 13 | 0.010 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1989 | 28 | 0.010 |
Why?
|
| Nerve Crush | 1 | 1989 | 1 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 1989 | 58 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 49 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1989 | 58 | 0.010 |
Why?
|
| Lasers | 1 | 1989 | 106 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 1989 | 75 | 0.010 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1983 | 7 | 0.000 |
Why?
|
| Carbohydrate Metabolism | 1 | 1983 | 30 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1989 | 2379 | 0.000 |
Why?
|
| Pregnancy | 1 | 1989 | 2894 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1987 | 1376 | 0.000 |
Why?
|